Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant

Overview of attention for article published in Frontiers in immunology, September 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 4 X users

Readers on

mendeley: 33 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 35,983 followers.

https://t.co/znv7ZVidaB

05 Nov 2019

Reply Repost Favourite

RT @immunotoxPhD: Great potential for novel #fluvaccines, especially H7N9. Perhaps opportunity to improve other potential mucosal vaccines…

03 Nov 2019

Reply Repost Favourite

Great potential for novel #fluvaccines, especially H7N9. Perhaps opportunity to improve other potential mucosal vaccines as well! #VaccinesWork #VaccinesSaveLives #immunology #mucosalimmunity

03 Nov 2019

Reply Repost Favourite

New Research: Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant: Influenza vaccines for H7N9 subtype have shown low immunogenicity in human clinical… https://t.co/tvSuoS

03 Nov 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.